Clinical Trial Update: Safety & Efficacy Study of Benzydamine Oral Rinse for the Treatment of Oral Mucositis (Mouth Sores) Resulting From Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, or Nasopharynx [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of benzydamine oral rinse for radiation-induced oral mucositis in head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of the Nasopharynx
• Cancer of the Oral Cavity
• Cancer of the Oropharynx
• Oral Mucositis

Drugs mentioned

• Benzydamine Oral Rinse (benzydamine)

Snippet

Sponsor: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. | Conditions: Stomatitis, Radiation Effects | Phase 3 | Status: COMPLETED